A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome
Titel:
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome
Auteur:
Vadhan-Raj, S. Fayad, L.E. Fanale, M.A. Pro, B. Rodriguez, A. Hagemeister, F.B. Bueso-Ramos, C.E. Zhou, X. McLaughlin, P.W. Fowler, N. Shah, J. Orlowski, R.Z. Samaniego, F. Wang, M. Cortes, J.E. Younes, A. Kwak, L.W. Sarlis, N.J. Romaguera, J.E.